CN101143169B - Traditional Chinese medicine preparation for curing peritoneal inflammation or pleural inflammation and its preparation method - Google Patents
Traditional Chinese medicine preparation for curing peritoneal inflammation or pleural inflammation and its preparation method Download PDFInfo
- Publication number
- CN101143169B CN101143169B CN2007101315371A CN200710131537A CN101143169B CN 101143169 B CN101143169 B CN 101143169B CN 2007101315371 A CN2007101315371 A CN 2007101315371A CN 200710131537 A CN200710131537 A CN 200710131537A CN 101143169 B CN101143169 B CN 101143169B
- Authority
- CN
- China
- Prior art keywords
- inflammation
- preparation
- portions
- examples
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medical preparation for remedying the abdominal inflammation or the thoracic inflammation, which is a tisane preparation that made from the following rawmaterials of drugs according to the weight ratio of 2 to 3 portions of rhubarbs, 3 to 4 portions of dyers woad leaves, 2 to 3 portions of dried gingers, 1 to 3 portions of foeniculum vulgare mill, 2 to 3 portions of finger citrons, 1 to 3 portions of rose flowers, 6 to 8 portions of Christina losesetrifes and 3 to 4 portions of red salvia roots. The manufacturing method of the tisane preparation is that the rhubarb, the dyers woad leaf, the dried ginger, the foeniculum vulgare mill, the finger citron, the rose flowers, the Christina losesetrife and the red salvia root are added with 8 to 15 times of water to be decocted for 4 to 5 hours and filtered, and the tisane preparation is obtained. The traditional Chinese medicine has obvious effect of remedying the abdominal inflammation or the thoracic inflammation.
Description
Technical field
The present invention relates to Chinese medicine and method for making, specifically relate to a kind of Chinese medicine preparation for the treatment of abdominal inflammation or thoracic cavity inflammation and preparation method thereof.
Background technology
Abdominal inflammation or thoracic cavity inflammation are clinical common diseases, if untimely control can lead to complications the serious harm human health.Acute hemorrhage necrotizing pancreatitis (AHNP) claims acute necrotizing pancreatitis (ANP), Severe Acute Pancreatitis SAP (SAP) again, is one of life-threatening abdominal inflammation serious symptom, and onset is anxious, progress is fast, and the state of an illness is complicated and changeable, and it is many to involve organ, complication is many, and mortality rate is up to 30%～60%.Domestic application combined therapy of Chinese and Western medicine treatment primary disease since 1958, be the oral medication administration, and not only gastrointestinal tract paralytic expansion during AHNP, and normal because of feel sick, vomiting has a strong impact on giving full play to of Chinese medicine effect, also makes its extensive use be subjected to limiting greatly.Up to the present, treatment by Chinese herbs effect is unsatisfactory.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine preparation for the treatment of abdominal inflammation or thoracic cavity inflammation and preparation method thereof.
The objective of the invention is to realize by following technical scheme:
A kind of Chinese medicine preparation for the treatment of abdominal inflammation or thoracic cavity inflammation is characterized in that it is by the made by weight ratio decoction of following bulk drugs:
Radix Et Rhizoma Rhei 2-3 part, Folium Isatidis 3-4 part, Rhizoma Zingiberis 2-3 part, Fructus Foeniculi 1-3 part, Fructus Citri Sarcodactylis 2-3 part, Flos Rosae Rugosae 1-3 part, Herba Lysimachiae 6-8 part, Radix Salviae Miltiorrhizae 3-4 part.
The dosage form of preparation can be decoction among the present invention, also can make the oral liquid of other form.
A kind of method for preparing the Chinese medicine preparation of treatment abdominal inflammation or thoracic cavity inflammation is characterized in that preparation process is as follows:
Get Radix Et Rhizoma Rhei 2-3 part, Folium Isatidis 3-4 part, Rhizoma Zingiberis 2-3 part, Fructus Foeniculi 1-3 part, Fructus Citri Sarcodactylis 2-3 part, Flos Rosae Rugosae 1-3 part, Herba Lysimachiae 6-8 part, Radix Salviae Miltiorrhizae 3-4 part, add 8-15 times of water gaging, decocted 4-5 hour, filter, obtain decoction.Wherein, every part of weight is 10 grams.
The application of above-mentioned Chinese medicine preparation in preparation treatment abdominal inflammation medicine.
The application of above-mentioned Chinese medicine preparation in preparation treatment thoracic cavity inflammation medicine.
The present invention is a raw material with Radix Et Rhizoma Rhei, Folium Isatidis, Rhizoma Zingiberis, Fructus Foeniculi, Fructus Citri Sarcodactylis, Flos Rosae Rugosae, Herba Lysimachiae and Radix Salviae Miltiorrhizae, makes Chinese medicine preparation, is applicable to treatment abdominal inflammation or thoracic cavity inflammation.This product is through clinical use, and curative effect is fine.
The specific embodiment
Embodiment 1
The Chinese medicine preparation of treatment abdominal inflammation or thoracic cavity inflammation, by the made by weight ratio medicament of following raw materials according:
2 parts of Radix Et Rhizoma Rhei, 4 parts of Folium Isatidiss, 2 parts of Rhizoma Zingiberiss, 3 parts of Fructus Foeniculi, 2 parts of Fructus Citri Sarcodactylis, 1 part of Flos Rosae Rugosae, 7 parts of Herba Lysimachiaes, 4 parts of Radix Salviae Miltiorrhizaes.Wherein, every part of weight is 10 grams.
Embodiment 2
The preparation method of the Chinese medicine preparation oral liquid of treatment abdominal inflammation or thoracic cavity inflammation:
Get 2 parts of Radix Et Rhizoma Rhei, 4 parts of Folium Isatidiss, 2 parts of Rhizoma Zingiberiss, 3 parts of Fructus Foeniculi, 2 parts of Fructus Citri Sarcodactylis, 1 part of Flos Rosae Rugosae, 7 parts of Herba Lysimachiaes, 4 parts of Radix Salviae Miltiorrhizaes, add 8-15 times of water gaging, wherein, every part of weight is 10 grams.Decocted 4-5 hour, and filtered, promptly get oral liquid potion (popular name: restore soup).
Embodiment 3
The test of pesticide effectiveness result of " recovery soup " treatment abdominal inflammation
1, physical data
Man's 33 examples, women 31 examples.14～80 years old age, average 55.9 years old, 33 examples (51.6%) more than 60 years old.Inducement: biliary tract 25 examples, eating and drinking too much at one meal 8 examples, fat 4 examples of eating, drug-induced 1 example, unknown cause 26 examples.All patients all have upper abdominal pain or full stomachache in various degree, companion's vomiting 42 examples, hematemesis 6 examples; Hyperpyrexia 10 examples, body temperature does not rise 2 examples; Pulse＞130 time/min 12 examples; Early stage shock (18 examples (13 examples are the gerontal patient) of blood pressure＜90/70mmHg); 3 examples of going into a coma.Upper abdomen peritonitis or full peritonitis are all arranged, abdominal distention 13 examples, obvious sign of ascites 12 examples, all subcutaneous hemorrhage 2 examples of umbilicus.Leukocyte 〉=15 * 109/L person, 42 examples; Blood amylase increases 46 examples, and amylase in urine increases 35 examples; Blood glucose＞11.1mmol/L person's 18 examples, blood calcium＜1.99mmol/L person's 3 examples, blood urea nitrogen＞7.1mmol/L person's 25 examples.Ultrasound diagnosis 26 example discovery pancreas enlargements 23 examples are inferior, ascites 12 routine times, and the interior opaque dark area of fluid of pancreas 5 examples are inferior, and all hydrops 5 examples of pancreas are inferior, and pancreatic pseudocyst 3 examples are inferior, gallbladder and choledocholithiasis 15 routine times.CT examination 15 examples are all seen the pancreas enlargement, and cholelithiasis choledocholithiasis 2 examples are inferior, and inhomogeneous low-density shadow 11 examples of pancreas are inferior, and all hydrops 8 examples of pancreas are inferior, and ascites 10 examples are inferior, pancreas pseudocyst 1 routine time, and pancreatic abscess 1 routine time, retroperitoneal abscess 1 is routine inferior.Abdominal paracentesis 18 examples, take out bloody ascites 15 examples, person's 12 examples that ascites amylase is higher than the blood amylase.
All cases are divided into two groups at random, and 40 examples are organized in treatment, matched group 24 examples, and two groups of case ordinary circumstances are learned processing by statistics, and there was no significant difference has comparability.
2, Therapeutic Method
The treatment group is taken recovery soup, obeys potion every day, the secondary sub-service, and 1 month is a course of treatment, serve on 2-3 the course of treatment.
Matched group: take cephalosporins (cephalosporin), 1 month is a course of treatment, serve on 2-3 the course of treatment.
3, observation index
Carry out symptom, sign scoring before and after the treatment, ultrasound diagnosis.
4, therapeutic outcome
(1) criterion of therapeutical effect
Recovery from illness: treatment pneumoretroperitoneum inflammation disappears, and checks normal.Syndrome, sign integration and minimizing 〉=95%.Drug withdrawal is not recurred in January.
Produce effects: treatment pneumoretroperitoneum inflammation disappears or obviously alleviates, and check result is normal.Syndrome, sign integration and minimizing 〉=70%,＜95%.
Effectively: treatment pneumoretroperitoneum inflammation alleviates, and check result is normal.Syndrome, sign integration and minimizing 〉=30%,＜70%.
Invalid: treatment back check result is normal.Disease nothing alleviates or has and increases the weight of, and inspection is treated preceding nothing improvement or increased the weight of to some extent.Syndrome, sign integration and minimizing＜30%.
(2), curative effect statistics
100 examples are organized in treatment, 64 examples of fully recovering (64%), and produce effects 27 (27%), effective 9 examples (9%), invalid 0 example, total effective rate is 100%.
Matched group 50 examples, 7 examples of fully recovering (14%), produce effects 6 (12%), effective 26 examples (52%), invalid 11 examples (22%), total effective rate is 78%.Two groups of total effective rates compare P＜0.05.
5, conclusion and discussion
Chinese medicine preparation restores soup treatment abdominal inflammation curative effect certainly.
Embodiment 4
The test of pesticide effectiveness result of " recovery soup " treatment thoracic cavity inflammation
1. physical data
Tried case totally 90 examples, be diagnosed as thoracic cavity inflammation.90 routine patients are divided into treatment group 45 example and matched group 45 examples at random, and two groups of physical data are similar, learn by statistics and handle, and there was no significant difference has comparability.
2, Therapeutic Method
Treatment group: give and restore the soup treatment, obey potion every day, the secondary sub-service.
Matched group is taken cephalosporins (cephalosporin).
Two groups was 1 course of treatment with 20 days all, finished drug withdrawal per course of treatment 3 days at interval, and logotype is carried out the curative effect statistics after 2 courses of treatment.
4. therapeutic outcome
(1) criterion of therapeutical effect
Recovery from illness: clinical symptom disappearance.
Effectively: clinical symptoms is improved.
Invalid: clinical symptoms does not have improvement substantially.
(2) curative effect statistics
45 examples are organized in treatment, 34 examples of wherein fully recovering (75,6%), and effective 11 examples (24,4%), invalid 0 example, total effective rate is 100%.
Matched group 45 examples, 10 examples of wherein fully recovering (22,2%), effective 22 examples (48,9%), invalid 13 examples (28,9%), total effective rate is 71,1%.
5, conclusion and discussion
Restore soup treatment thoracic cavity inflammation determined curative effect.Through clinical observation, restore the soup total effective rate and reach 100%.Result of study shows that restoring soup is the active drug of treatment thoracic cavity inflammation.
Embodiment 5
The Chinese medicine preparation of treatment abdominal inflammation or thoracic cavity inflammation, raw material weight proportioning are done to change slightly, by the made by weight ratio medicament of following raw materials according;
3 parts of Radix Et Rhizoma Rhei, 3 parts of Folium Isatidiss, 3 parts of Rhizoma Zingiberiss, little
1 part of perfume, 3 parts of Fructus Citri Sarcodactylis, 3 parts of Flos Rosae Rugosaes, 6 parts of Herba Lysimachiaes, 4 parts of Radix Salviae Miltiorrhizaes.Wherein, every part of weight is 10 grams.
Embodiment 6
The preparation method of the Chinese medicine preparation oral liquid of treatment abdominal inflammation or thoracic cavity inflammation:
Get 3 parts of Radix Et Rhizoma Rhei, 3 parts of Folium Isatidiss, 3 parts of Rhizoma Zingiberiss, little
1 part of perfume, 3 parts of Fructus Citri Sarcodactylis, 3 parts of Flos Rosae Rugosaes, 6 careless parts of money, 4 parts of Radix Salviae Miltiorrhizaes add 8-15 times of water gaging, and wherein, every part of weight is 10 grams.Decocted 4-5 hour, and filtered, promptly get oral liquid potion (popular name: restore soup).
Equally, gained is restored soup be used for the treatment of abdominal inflammation or thoracic cavity inflammation, effect is remarkable.
Claims (4)
1. a Chinese medicine preparation for the treatment of abdominal inflammation or thoracic cavity inflammation is characterized in that it is by the made by weight ratio decoction of following bulk drugs;
Radix Et Rhizoma Rhei 2-3 part, Folium Isatidis 3-4 part, Rhizoma Zingiberis 2-3 part, Fructus Foeniculi 1-3 part, Fructus Citri Sarcodactylis 2-3 part, Flos Rosae Rugosae 1-3 part, Herba Lysimachiae 6-8 part, Radix Salviae Miltiorrhizae 3-4 part.
2. method for preparing the described Chinese medicine preparation of claim 1 is characterized in that preparation process is as follows:
Get Radix Et Rhizoma Rhei 2-3 part, Folium Isatidis 3-4 part, Rhizoma Zingiberis 2-3 part, Fructus Foeniculi 1-3 part, Fructus Citri Sarcodactylis 2-3 part, Flos Rosae Rugosae 1-3 part, Herba Lysimachiae 6-8 part, Radix Salviae Miltiorrhizae 3-4 part, add 8-15 times of water gaging, decocted 4-5 hour, filter, obtain decoction.
3. the application of Chinese medicine preparation as claimed in claim 1 in preparation treatment abdominal inflammation medicine.
4. the application of Chinese medicine preparation as claimed in claim 1 in preparation treatment thoracic cavity inflammation medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101315371A CN101143169B (en) | 2007-09-04 | 2007-09-04 | Traditional Chinese medicine preparation for curing peritoneal inflammation or pleural inflammation and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101315371A CN101143169B (en) | 2007-09-04 | 2007-09-04 | Traditional Chinese medicine preparation for curing peritoneal inflammation or pleural inflammation and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101143169A CN101143169A (en) | 2008-03-19 |
| CN101143169B true CN101143169B (en) | 2010-06-09 |
Family
ID=39206024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101315371A Expired - Fee Related CN101143169B (en) | 2007-09-04 | 2007-09-04 | Traditional Chinese medicine preparation for curing peritoneal inflammation or pleural inflammation and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101143169B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1076626A (en) * | 1993-01-19 | 1993-09-29 | 李先文 | Medicine taken after being mixed with boiling water for liver trouble |
-
2007
- 2007-09-04 CN CN2007101315371A patent/CN101143169B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1076626A (en) * | 1993-01-19 | 1993-09-29 | 李先文 | Medicine taken after being mixed with boiling water for liver trouble |
Non-Patent Citations (2)
| Title |
|---|
| 董正昌等.浅谈治疗肝病十法.中医药临床杂志17 5.2005,17(5),443-444. |
| 董正昌等.浅谈治疗肝病十法.中医药临床杂志17 5.2005,17(5),443-444. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101143169A (en) | 2008-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102755594B (en) | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof | |
| CN101703708A (en) | Chinese medicinal preparation for treating rheumatoid arthritis and gout, and preparation method thereof | |
| CN101757566A (en) | Traditional Chinese medicine composition for treating colon cancer and preparation method thereof | |
| CN102178800B (en) | Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN102284049B (en) | A kind ofly alleviate compound Chinese medicinal preparation of chemicotherapy toxicity and uses thereof | |
| CN102526327B (en) | Compound Chinese herbal medicine for treating rheumatoid bone disease and preparation method for compound Chinese herbal medicine | |
| CN101961480A (en) | Traditional Chinese medicinal composition for treating hematochezia and preparation method thereof | |
| CN104306837A (en) | Baibei anti-tuberculosis pill for treating pulmonary tuberculosis, tuberculous pleuritis, peritonitis, empyema and bronchopleural fistula | |
| CN100457170C (en) | A Medicine for treatment of gastrointestinal diseases | |
| CN102198243B (en) | Oviduct dredging medicament for removing blood stasis and warming meridians | |
| CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN101884779A (en) | Siberian solomonseal rhizome composition for intervening sub-health state and preparation method thereof | |
| CN104288624A (en) | Pharmaceutical composition and application thereof | |
| CN103127485A (en) | Medicine for treating tumors | |
| CN103285173B (en) | A kind of Chinese medicine treating thrombocytopenic purpura | |
| CN105832991A (en) | Traditional Chinese medicine composition for treating gastritis | |
| CN104758686A (en) | Traditional Chinese medicine preparation for treating poor sleep quality | |
| CN102526620B (en) | Traditional Chinese medicinal composition for treating gynecological inflammation and application of same | |
| CN103405732A (en) | Traditional Chinese medicine patch for treating infant rotavirus enteritis and preparation method thereof | |
| CN101143169B (en) | Traditional Chinese medicine preparation for curing peritoneal inflammation or pleural inflammation and its preparation method | |
| CN105327182A (en) | Medicine for treating child pertussis and preparation method thereof | |
| CN106110124A (en) | A kind of antituberculotic Chinese medicine composition | |
| CN104940813A (en) | Traditional Chinese medicine composition for treating cholelithiasis and cholecystitis, and preparation method thereof | |
| CN103830481A (en) | Medicine for treating recurrent respiratory tract infection of children | |
| CN103239503A (en) | Chinese medicine preparation for treating itai-itai disease and preparation method of Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100609 Termination date: 20140904 |
|
| EXPY | Termination of patent right or utility model |